BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$803M |
| 2 |
iShares MSCI South Korea ETF
EWY
|
+$683M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$676M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$612M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$570M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.92B |
| 2 |
Meta Platforms (Facebook)
META
|
+$899M |
| 3 |
Amazon
AMZN
|
+$705M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$698M |
| 5 |
GE Vernova
GEV
|
+$545M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Financials | 7.92% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Healthcare | 6.49% |
| 5 | Industrials | 5.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
PUT
Labcorp
LH
$25.2B
| $3.47M | ﹤0.01% |
+130
| New | +$35.2K |
|
|
PVLA
2202
Palvella Therapeutics
PVLA
$2.05B
| $3.46M | ﹤0.01% |
27,781
+27,311
| +5,811% | +$2.85M |
|
2203
Nurix Therapeutics
NRIX
$2.45B
| $3.46M | ﹤0.01% |
223,363
+91,269
| +69% | +$1.51M |
|
2204
CALL
Wynn Resorts
WYNN
$10.3B
| $3.44M | ﹤0.01% |
339
-283
| -45% | -$31K |
|
2205
First Horizon
FHN
$12.2B
| $3.44M | ﹤0.01% |
150,928
+3,045
| +2% | +$72.8K |
|
2206
SouthState Bank Corp
SSB
$10.3B
| $3.43M | ﹤0.01% |
37,054
+25,529
| +222% | +$2.5M |
|
2207
PUT
SAP
SAP
$215B
| $3.42M | ﹤0.01% |
200
| – | – |
|
2208
Benchmark Electronics
BHE
$2.66B
| $3.42M | ﹤0.01% |
61,004
+19,897
| +48% | +$1.07M |
|
|
DNMX
2209
Dynamix Corp III
DNMX
$269M
| $3.42M | ﹤0.01% |
+344,634
| New | +$3.42M |
|
|
MKLY
2210
McKinley Acquisition Corp
MKLY
$248M
| $3.42M | ﹤0.01% |
339,694
+40,265
| +13% | +$404K |
|
|
EVOX
2211
Evolution Global Acquisition Corp
EVOX
$322M
| $3.4M | ﹤0.01% |
341,162
+31,238
| +10% | +$312K |
|
2212
Artivion
AORT
$1.34B
| $3.39M | ﹤0.01% |
92,650
+3,115
| +3% | +$123K |
|
2213
CALL
NRG Energy
NRG
$26.2B
| $3.39M | ﹤0.01% |
+232
| New | +$36.5K |
|
2214
Gold Royalty Corp
GROY
$602M
| $3.39M | ﹤0.01% |
946,834
+228,708
| +32% | +$977K |
|
2215
NOV
NOV
$6.84B
| $3.39M | ﹤0.01% |
179,976
+103,989
| +137% | +$1.95M |
|
2216
National Fuel Gas
NFG
$7.69B
| $3.38M | ﹤0.01% |
35,989
+8,971
| +33% | +$783K |
|
2217
Arrow Electronics
ARW
$10.5B
| $3.38M | ﹤0.01% |
23,579
+10,513
| +80% | +$1.44M |
|
2218
Gildan
GIL
$9.49B
| $3.37M | ﹤0.01% |
60,637
-8,632
| -12% | -$558K |
|
2219
Webster Financial
WBS
$12.3B
| $3.37M | ﹤0.01% |
48,500
+24,222
| +100% | +$1.66M |
|
2220
Pediatrix Medical
MD
$2.2B
| $3.36M | ﹤0.01% |
157,238
+13,294
| +9% | +$277K |
|
2221
Hycroft Mining Holding Corp
HYMC
$1.79B
| $3.36M | ﹤0.01% |
95,510
+95,097
| +23,026% | +$3.68M |
|
2222
Pathward Financial
CASH
$1.88B
| $3.36M | ﹤0.01% |
37,639
+4,293
| +13% | +$374K |
|
2223
Aquestive Therapeutics
AQST
$452M
| $3.36M | ﹤0.01% |
809,007
-362,668
| -31% | -$1.47M |
|
2224
Vericel Corp
VCEL
$2.38B
| $3.35M | ﹤0.01% |
104,287
+25,802
| +33% | +$916K |
|
2225
Surgery Partners
SGRY
$2.15B
| $3.35M | ﹤0.01% |
281,352
+164,994
| +142% | +$2.37M |
|
Similar funds
BNP Paribas Financial Markets's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Financial Markets held 6,247 positions worth $206B, down 6.7% from $221B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets's Q1 2026 filing shows 521 new, 2,339 increased, 2,351 reduced and 443 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,501,253 shares worth $112M. The largest sale was Apple, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q1 2026 buy was Vanguard Long-Term Corporate Bond ETF: 1,501,253 shares worth $112M.
- BNP Paribas Financial Markets added most to Oracle in Q1 2026, an estimated $803M increase.
- BNP Paribas Financial Markets's biggest Q1 2026 reduction was Apple, cutting an estimated $1.92B.
- BNP Paribas Financial Markets fully exited Flutter Entertainment in Q1 2026, selling an estimated $332M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $206B portfolio in Q1 2026.
- BNP Paribas Financial Markets opened 521 new positions and closed 443 in Q1 2026.
- BNP Paribas Financial Markets's portfolio value fell 6.7% quarter-over-quarter to $206B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.